Evan E Opas
Overview
Explore the profile of Evan E Opas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li D, Opas E, Tuluc F, Metzger D, Hou C, Hakonarson H, et al.
J Clin Endocrinol Metab
. 2014 May;
99(9):E1774-83.
PMID: 24823460
Context: Most cases of autosomal dominant hypoparathyroidism (ADH) are caused by gain-of-function mutations in CASR or dominant inhibitor mutations in GCM2 or PTH. Objective: Our objectives were to identify the...
2.
Yuan Z, Opas E, Vrikshajanani C, Libutti S, Levine M
Transgenic Res
. 2014 Apr;
23(4):631-41.
PMID: 24736975
Glial cells missing homolog 2 (GCM2) is a transcription factor that is expressed predominately in the pharyngeal pouches and, at later stages, in the developing and mature parathyroid glands. In...
3.
Schmidt A, Meissner R, Gentile M, Chisamore M, Opas E, Scafonas A, et al.
J Steroid Biochem Mol Biol
. 2014 Feb;
143:29-39.
PMID: 24565564
Prostate cancer (PCa) initially responds to inhibition of androgen receptor (AR) signaling, but inevitably progresses to hormone ablation-resistant disease. Much effort is focused on optimizing this androgen deprivation strategy by...
4.
Schmidt A, Kimmel D, Bai C, Scafonas A, Rutledge S, Vogel R, et al.
J Biol Chem
. 2010 Apr;
285(22):17054-64.
PMID: 20356837
Selective androgen receptor modulators (SARMs) are androgen receptor (AR) ligands that induce anabolism while having reduced effects in reproductive tissues. In various experimental contexts SARMs fully activate, partially activate, or...
5.
Opas E, Scafonas A, Nantermet P, Wilkening R, Birzin E, Wilkinson H, et al.
Maturitas
. 2009 Aug;
64(1):46-51.
PMID: 19679413
Objective: To test the role of ERbeta in the control of estrogen-dependent thermoregulation in rats. Methods: Test the ability of an ERbeta-selective ligand to suppress the elevation in basal rat...
6.
Opas E, Gentile M, Kimmel D, Rodan G, Schmidt A
Maturitas
. 2005 May;
53(2):210-6.
PMID: 15908148
Objective: Estrogen is the most effective treatment for preventing the vasomotor symptoms in women. The ability of estrogen to control tail skin temperature (TST) in rats is used as an...
7.
Schmidt A, Vogel R, Rutledge S, Opas E, Rodan G, Friedman E
Pharmacol Biochem Behav
. 2005 Mar;
80(3):379-85.
PMID: 15740779
Nuclear receptors are transcription factors that usually interact, in a ligand-dependent manner, with specific DNA sequences located within promoters of target genes. The nuclear receptors can also be controlled in...
8.
Opas E, Rutledge S, Vogel R, Rodan G, Schmidt A
Maturitas
. 2004 Jul;
48(4):463-71.
PMID: 15283940
Objective: Develop a rat model for the evaluation of estrogenic agents on estrogen deficiency-induced changes in thermoregulation. Methods: OVX rats are impaired in thermoregulation which manifests itself as an elevation...